| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Revenue | 267.1 | 239.6 |
| Gross profit | 72.3 | 58.2 |
| Profit before tax | 45.8 | 35.9 |
| Net income | 34.1 | 27.9 |
| EPS (diluted, $ a share) | $0.67 | $0.54 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +22.1% |
|---|---|
| Revenue, year on year | +11.5% |
| Gross margin | 27.1% |
10-Q filed with the SEC, NASDAQ: CRVL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Corvel Corp: key numbers
- Share price
- $87.62Close, Nov 17
- Market cap
- $4.41B
- Shares outstanding
- 50.35MLatest SEC cover page
- Sector
- Finance
- Industry
- Insurance Agents, Brokers & ServiceSIC 6411
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Corvel Corp
All →Corvel Insider Steven J. Hamerslag Sells $924K of Stock
Steven J. Hamerslag sold 11,000 shares of Corvel Corp at $84.04 a share, worth $924K in total on Nov 11, 2026. Shares held after the trade: 276,000 (-3.8%).
- Value
- $924K
- Shares
- 11,000
- Price
- $84.04
- Holding change
- -3.8%
- Trade date
- Nov 11, 2026
Corvel Insider R. Judd Jessup Sells $576K of Stock
R. Judd Jessup sold 6,939 shares of Corvel Corp at $83.01 a share, worth $576K in total on Nov 9, 2026. Shares held after the trade: 104,859 (-6.2%).
- Value
- $576K
- Shares
- 6,939
- Price
- $83.01
- Holding change
- -6.2%
- Trade date
- Nov 9, 2026
CorVel Earnings Call: Key Takeaways
CorVel achieved a $1 billion trailing 12-month revenue milestone with strong 11% year-over-year growth and significant margin expansion driven by AI-integrated claims management.
Corvel Financial Results
CorVel Corporation reported financial results for its second fiscal quarter ended September 30, 2026, with quarterly revenue increasing 11% year-over-year to $267 million. Diluted earnings per share rose 24% to $0.67, driven by strong momentum in workers' compensation and liability businesses and the implementation of new national health plan contracts within its CERIS division.
- Term
- Q2 2027